Toludesvenlafaxine for non-specific low back pain
Official title: Efficacy and Safety of Toludesvenlafaxine in the Treatment of Non-specific Low Back Pain
Run by Beijing Tiantan Hospital · NCT07709416 · Data updated 2026-11-12
This study tests toludesvenlafaxine to help adults with chronic non-specific low back pain see if it reduces their pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 132 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | July 15, 2026 |
| Main results expected | September 1, 2028 |
| Study ends | December 1, 2028 |
| Registry record updated | July 27, 2026 |
| Trial ID | NCT07709416 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 to 75 with chronic non-specific low back pain (pain below the costal margin and above the inferior gluteal folds) lasting more than 3 months and moderate to severe intensity (NRS ≥ 3), without depression or prior antidepressant use.
✕Probably not a fit
Patients with depression, prior antidepressant use, opioid use, or specific spinal pathology may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates toludesvenlafaxine as an active comparator for adults with chronic non-specific low back pain. Participants are adults 18 to 75 with moderate to severe pain lasting at least 3 months and no identifiable spinal pathology. The trial focuses on pain reduction as the primary outcome, using standard pain scales, under controlled conditions to compare toludesvenlafaxine with a reference treatment. Exclusion criteria include depression, prior antidepressant use, opioid use, and other conditions that could confound results. The lead sponsor is Beijing Tiantan Hospital, with recruitment centered in Beijing, China.
Why it matters
Potential benefit: If successful, Toludesvenlafaxine could provide an effective option for reducing chronic non-specific low back pain and improving quality of life.
How similar studies have gone: Prior research in similar antidepressant classes has shown mixed results for chronic low back pain; this study aims to clarify toludesvenlafaxine's role.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 to 75 years. * Diagnosis of chronic nonspecific low back pain, defined as pain located below the costal margin and above the inferior gluteal folds, lasting for more than 3 months, without a specific pathological cause. * Moderate to severe pain, defined as a Numerical Rating Scale score of 3 or higher. * Able to understand the study procedures and sign written informed consent. Exclusion Criteria: * Low back pain caused by a known specific pathological condition, including but not limited to fracture, malignancy, infection, inflammatory disease, or other identifiable structural or systemic causes. * Major comorbidities that may interfere with study outcomes or represent contraindications to the study medication. * Current or previous diagnosis of depression, regardless of whether treatment was received. * Current or previous use of antidepressant medication. * Current use of opioid analgesics. * Pregnancy, breastfeeding, or planned pregnancy during the study period. * Known allergy, hypersensitivity, or contraindication to toludesvenlafaxine. * History of psychosis or other major psychiatric disorders. * Any condition that, in the investigator's judgment, makes the participant unsuitable for the study.
Where it's running
-
Fang Luo
Beijing, China Recruiting
Study contacts
- Study coordinator: Fang Luo
- Email: 13611326978@163.com
- Phone: +8659976661
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pelvic Control Training with Biofeedback vs Core Stability for Non-Specific Low Back Pain
This trial tests whether pelvic control training using a pressure biofeedback unit helps people with non-specific low back pain more than standard core stability exercises.
-
Wearable MMG belt with haptics and games to motivate core exercises
This trial will test whether a wearable mechanomyography (MMG) biofeedback belt with a haptic-enabled mobile app and game features helps adults with chronic non-specific low back pain perform core exercises, reduce pain, and lower disability over 8 weeks.
-
Pilates for postural correction, core strength, and flexibility in young adults with non-specific low backache
This trial tests whether a six-week, three-times-weekly Pilates program improves posture, core strength, and flexibility more than conventional therapy in 18–25-year-olds with non-specific low backache.
-
Motorized versus standard lumbar support for non-specific low back pain
This test will see if a motorized, battery-powered lumbar support reduces pain and improves daily function more than a standard semi-rigid support in adults with non-specific low back pain.
-
Myofascial Trigger Point Therapy vs. a Specific Exercise Program for Nonspecific Low Back Pain
This study tests whether hands-on trigger point therapy, a guided exercise program, or both can reduce pain and improve function in adults with nonspecific low back pain.
-
Exercise effect on the lumbar multifidus in back pain
This study tests whether a 12-week home rehab program can change ultrasound features of the lumbar multifidus and reduce pain in adults with chronic non-specific low back pain from multifidus injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.